Search - tctmd.com

Presenter: Tsuyoshi Osue, Junya Shite, Toshirou Shinke, Hiromasa Otake, Masayuki Nakagawa, Ryouji Nagoshi, Takumi Inoue, Amane Kozuki, Hirotoshi Hariki, Masamichi Iwasaki, Yu Taniguchi, Hiroto Kinutani, Akihide Konishi, Ryo Nishio, Noritoshi Hiranuma, Ken-ichi Hirata

January 03, 2012

Presentation TCT 2012

Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberté Paclitaxel-Eluting Stents.

Presenter: Dean J. Kereiakes, Louis A. Cannon, John A. Ormiston, Hong Wang, Paul L. Underwood, Keith D. Dawkins

January 03, 2012

Presentation TCT 2012

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

Presenter: Michael Werk, Thomas Albrecht, Dirk R. Meyer, Heiner Stiepani, Beatrix Schnorr, Enrique Lopez H?nninen

January 03, 2012

Presentation TCT 2012

No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

Presenter: James P. Howard, Zia Buckhoree, Dan A. Jones, Sean M. Gallagher, Krishnaraj S. Rathod, Ajay K. Jain, Charles Knight, Anthony Mathur, Andrew Wragg

January 03, 2012

Presentation TCT 2012

Long-term outcome after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a...

Presenter: Petri O. Tuomainen, Antti Ylitalo, Matti Niemel?, Mikko Pietil?, Jussi Sia, Kai Nyman, Juhani Airaksinen, Pasi P. Karjalainen

January 03, 2012

Advertisement

SES Effective for Both Focal, Diffuse DES Restenosis

El SLS es Efectivo contra la Reestenosis tanto Focal como Difusa del SLF

TCTMD’s Top 10 Most Popular News Stories From 2011

Los 10 Artículos Más Populares de TCTMD de 2011

Study Finds No ‘Obesity Paradox’ in DES-Treated Patients

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

El Riesgo de Trombosis del Stent es Menor con Xience que con SLF de 1ª Generación

El Estudio no Halla “Paradoja de la Obesidad” alguna en Pacientes Tratados con SLF

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

Estudio prospectivo multicentro comparativo entre la angioplastia con globo de paclitaxel y globo convencional contra la reestenosis de SLF

A Prospective Multicenter Trial Comparing Paclitaxel-Coated Balloon Angioplasty with Uncoated Balloon Angioplasty in DES Restenosis

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Ensayo Aleatorizado Multicentro Comparador de Amfilimus con Stents Liberadores de Paclitaxel en Lesiones Coronarias Nativas De Novo

A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions

Uniform Vessel Healing after Everolimus-eluting Stent implantation: Detailed Comparison with Paclitaxel-eluting Stent by Optical Coherence Tomography

Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberté Paclitaxel-Eluting Stents.

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

Long-term outcome after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content